XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (10,482,761) $ (8,284,084)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 155,349 133,028
Amortization 15,789 5,828
Amortization of right-of-use assets 260,819 299,171
Share-based compensation expense 549,208 181,598
Loss on property and equipment dispositions 53,173 0
Amortization of debt issuance costs and discount 746,612 544,363
Changes in operating assets and liabilities:    
Accounts receivable 233,789 6,371
Inventory (2,186,415) (648,462)
Prepaid and other assets 165,056 (173,828)
Accounts payable 1,758,162 (223,682)
Accrued expenses (98,297) (557,944)
Lease liabilities (264,580) (137,482)
Other liabilities (23,854) (39,657)
Net cash used in operating activities (9,117,950) (8,894,780)
Cash flows from investing activities:    
Acquisition of patents (2,733) (50,145)
Purchases of property and equipment (190,834) (246,978)
Net cash used in investing activities (193,567) (297,123)
Cash flows from financing activities:    
Proceeds from the issuance of common stock in June 2025 financing 4,510,001 0
Issuance costs for June 2025 financing (804,940) 0
Proceeds from at-the-market sales of common stock 5,496,791 1,021,994
Issuance costs for at-the-market sales of common stock (164,904) (30,660)
Proceeds from common stock issued through ESPP 40,875 10,390
Net cash provided by financing activities 9,077,823 1,001,724
Net change in cash and cash equivalents (233,694) (8,190,179)
Cash and cash equivalents:    
Beginning of period 3,451,761 21,716,077
End of period 3,218,067 13,525,898
Cash paid for:    
Taxes 6,006 4,550
Non-cash investing and financing activities:    
Property and equipment costs included in accounts payable 83,602 37,370
Acquisition of patents included in accounts payable 2,776 0
Issuance of warrants for underwriter commission 56,035 0
Deferred offering costs reclassified to additional paid-in-capital 13,283 1,586
Conversion of convertible notes into common stock $ 85,000 $ 0